Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Autologous

Allogeneic, unrelated

Allogeneic, related

Bone marrow

PBSC

Single cord blood unit

Multiple cord blood units

Other product

Specify:

Visit

100 day 1 year

Disease Assessment since the Date of Last Report Questions: 1 - 25

Spleen size1

Known

Unknown

Not applicable (splenectomy)

Specify the spleen size:2 centimeters below right costal margin

Was presence of somatic mutations tested?

Yes No Unknown

3

Date sample collected:4 __ __ __ __ - __ __- __ __

Specify sample source

Bone marrow Peripheral blood

5

JAK 2

Positive Negative Not done

6

CALR1

Positive Negative Not done

7

CALR2

Positive Negative Not done

8

MPL

Positive Negative Not done

9

ASXL1

Positive Negative Not done

10

SRSF2

Positive Negative Not done

11

EZH2

Positive Negative Not done

12

IDH1

Positive Negative Not done

13

IDH2

Positive Negative Not done

14

LNK

Positive Negative Not done

15

CBL

Positive Negative Not done

16

TET2

Positive Negative Not done

17

IKZF1

Positive Negative Not done

18

DNMT3A

Positive Negative Not done

19

TP53

Positive Negative Not done

20

SF3B1

Positive Negative Not done

21

U2AF1

Positive Negative Not done

22

FLT3

Positive Negative Not done

23

Disease Assessment since the Date of Last Report (1) Questions: 24 - 25

Other gene mutation

Positive Negative Not done

24

Specify other gene mutation:25

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

HCT type: (check all that apply)

Product type: (check all that apply)

Specify the laboratory values since the date of last report:

Center: CRID: 

Form 2557 R1.0: Myelofibrosis CMS Study Post-HCT Supplemental Form

CIBMTR Form 2557 revision 1.0 last updated January 2017 
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 1 / 2



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Autologous

Allogeneic, unrelated

Allogeneic, related

Bone marrow

PBSC

Single cord blood unit

Multiple cord blood units

Other product

Specify:

Visit

100 day 1 year

Disease Assessment since the Date of Last Report Questions: 1 - 25

Spleen size1

Known

Unknown

Not applicable (splenectomy)

Specify the spleen size:2 centimeters below right costal margin

Was presence of somatic mutations tested?

Yes No Unknown

3

Date sample collected:4 __ __ __ __ - __ __- __ __

Specify sample source

Bone marrow Peripheral blood

5

JAK 2

Positive Negative Not done

6

CALR1

Positive Negative Not done

7

CALR2

Positive Negative Not done

8

MPL

Positive Negative Not done

9

ASXL1

Positive Negative Not done

10

SRSF2

Positive Negative Not done

11

EZH2

Positive Negative Not done

12

IDH1

Positive Negative Not done

13

IDH2

Positive Negative Not done

14

LNK

Positive Negative Not done

15

CBL

Positive Negative Not done

16

TET2

Positive Negative Not done

17

IKZF1

Positive Negative Not done

18

DNMT3A

Positive Negative Not done

19

TP53

Positive Negative Not done

20

SF3B1

Positive Negative Not done

21

U2AF1

Positive Negative Not done

22

FLT3

Positive Negative Not done

23

Disease Assessment since the Date of Last Report (1) Questions: 24 - 25

Other gene mutation

Positive Negative Not done

24

Specify other gene mutation:25

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

HCT type: (check all that apply)

Product type: (check all that apply)

Specify the laboratory values since the date of last report:

Center: CRID: 

Form 2557 R1.0: Myelofibrosis CMS Study Post-HCT Supplemental Form

CIBMTR Form 2557 revision 1.0 last updated January 2017 
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 2 / 2